Page last updated: 2024-08-25

chitosan and Lymphoma, B-Cell

chitosan has been researched along with Lymphoma, B-Cell in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Argenziano, M; Bittolo, T; Bomben, R; Bozzer, S; Busato, D; Capolla, S; Cavalli, R; D'Agaro, T; Dal Bo, M; De Leo, L; Gattei, V; Macor, P; Not, T; Toffoli, G1
Albanese, S; Auletta, L; Fiorenza, D; Gramanzini, M; Greco, A; Grimaldi, AM; Iaccino, E; Netti, PA; Orlandella, FM; Palmieri, C; Quinto, I; Salvatore, G; Salvatore, M; Sandomenico, A; Sarnataro, D; Scala, G; Torino, E; Vecchione, D1
Lobato, ZI; Mansur, AA; Mansur, HS; Soriano-Araújo, A1

Other Studies

3 other study(ies) available for chitosan and Lymphoma, B-Cell

ArticleYear
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models.
    Frontiers in immunology, 2023, Volume: 14

    Topics: Animals; Antagomirs; B-Lymphocytes; Chitosan; Humans; Lymphoma, B-Cell; Mice; MicroRNAs; Tumor Microenvironment

2023
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles.
    Nanomedicine : nanotechnology, biology, and medicine, 2018, Volume: 14, Issue:2

    Topics: Animals; Chitosan; Humans; Hyaluronic Acid; Lymphoma, B-Cell; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Nanoparticles; Peptide Fragments; Theranostic Nanomedicine; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
Fluorescent nanohybrids based on quantum dot-chitosan-antibody as potential cancer biomarkers.
    ACS applied materials & interfaces, 2014, Jul-23, Volume: 6, Issue:14

    Topics: Antibodies, Neoplasm; Antigens, CD20; B-Lymphocytes; Biomarkers, Tumor; Cell Line, Tumor; Chitosan; Humans; Lymphoma, B-Cell; Optical Imaging; Quantum Dots

2014